Orthofix Reports Q1 2026 Earnings with 3% Pro Forma Constant Currency Sales Growth
Orthofix (OFIX) reported Q1 2026 earnings with total global net sales of $196.4 million, representing 3% pro forma constant currency growth. The company saw growth in several segments, including Spine Fixation and Therapeutic Solutions, though U.S. Limb Reconstruction sales were flat. The pro forma non-GAAP adjusted gross margin improved to 70.7%.

Topics: Earnings Financial Performance Sales Growth Spine Fixation Therapeutic Solutions